These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4890296)

  • 1. A double blind study of the effect of tranexamic acid in essential menorrhagia.
    Vermylen J; Verhaegen-Declercq ML; Fierens F; Verstraete M
    Bull Soc R Belge Gynecol Obstet; 1968; 38(5):385-90. PubMed ID: 4890296
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.
    Weström L; Bengtsson LP
    J Reprod Med; 1970 Oct; 5(4):154-61. PubMed ID: 4940818
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of menorrhagia with tranexamic acid. A double-blind trial.
    Callender ST; Warner GT; Cope E
    Br Med J; 1970 Oct; 4(5729):214-6. PubMed ID: 4919554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
    Bengtsson LP; Weström L
    Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid (Lysteda) for treatment of menorrhagia.
    Med Lett Drugs Ther; 2010 Jul; 52(1342):54-5. PubMed ID: 20622806
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of idiopathic menorrhagia with tranexamic acid.
    Srinil S; Jaisamrarn U
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OTC tranexamic acid for heavy menstrual bleeding?
    Drug Ther Bull; 2011 Jan; 49(1):6-8. PubMed ID: 21220253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind study of the effect of tranexamic acid in essential menorrhagia.
    Vermylen J; Verhaegen-Declercq ML; Verstraete M; Fierens F
    Thromb Diath Haemorrh; 1968 Dec; 20(3):583-7. PubMed ID: 5710474
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new antifibrinolytic agent (cyclokapron) with effect against menorrhagia].
    Tidsskr Nor Laegeforen; 1969 Sep; 89(18):1437. PubMed ID: 5376311
    [No Abstract]   [Full Text] [Related]  

  • 10. Menorrhagia.
    Duckitt K; McCully K
    Clin Evid; 2004 Dec; (12):2639-63. PubMed ID: 15865811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antifibrinolytic and antihemorrhagic activity of trans-aminomethyl cyclohexane carboxylic acid (AMCHA). Clinical experience].
    Avanzi G
    Minerva Med; 1972 Dec; 63(87):4758-66. PubMed ID: 4565687
    [No Abstract]   [Full Text] [Related]  

  • 12. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.
    Kouides PA; Byams VR; Philipp CS; Stein SF; Heit JA; Lukes AS; Skerrette NI; Dowling NF; Evatt BL; Miller CH; Owens S; Kulkarni R
    Br J Haematol; 2009 Apr; 145(2):212-20. PubMed ID: 19236375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
    Lakhani KP; Marsh MS; Purcell W; Hardiman P
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of fibrinolysis in excessive menstrual bleeding].
    Bar-Am A; Toaf FR; Hertzberg M
    Harefuah; 1976 Feb; 90(4):162-4. PubMed ID: 1269998
    [No Abstract]   [Full Text] [Related]  

  • 15. [The antifibrinolytic therapy of gynecologic hemorrhages].
    Koutský J; Padovec J; Jirásek JE; Rybák M; Hladovec J; Mansfeld V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):151-65. PubMed ID: 4174653
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
    Sundström A; Seaman H; Kieler H; Alfredsson L
    BJOG; 2009 Jan; 116(1):91-7. PubMed ID: 19016686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a new potent antifibrinolytic agent, tranexamic acid.
    Kobayashi T; Sugiura J
    J Jpn Obstet Gynecol Soc; 1966 Jul; 13(3):158-67. PubMed ID: 5341162
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of menorrhagia with tranexamic acid. A clinical trial of an underestimated problem in general practice].
    Drøsdal H
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2907-10. PubMed ID: 8236193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate.
    Kriplani A; Kulshrestha V; Agarwal N; Diwakar S
    J Obstet Gynaecol; 2006 Oct; 26(7):673-8. PubMed ID: 17071438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypermenorrhea with tranexamic acid].
    Petersen K; Jelert H; Diernaes E; Detlefsen GU
    Ugeskr Laeger; 1983 Sep; 145(36):2759-60. PubMed ID: 6356545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.